Explicit Underweight rating validates sub-neutral sizing without forcing fresh capital action near 200 SMA pivot; trim into rallies toward $66.05-$67.00 only
The sub-neutral sizing (3-4% portfolio / 75% model-weight inherited from the 8/14 trim) is already the operational Underweight; the explicit Underweight rating makes the bear case legible without forcing capital action that would violate the prior 8/14 reflection against compounding trim overshoot near oversold RSI at the 200 SMA. Execute confirmation-based escalation triggers (weekly close <$64.26 with volume >15M) rather than proximity-based exits; trim into rallies ($66.05-$67.00), not into weakness ($65.19).
| Position | Action |
|---|---|
| Current position | Sub-neutral weight at 3-4% of portfolio / 75% of model-weight |
| Weekly close <$64.26 (200 SMA) with volume >15M | Trim 25-30% of remaining position |
| Daily close <$60 | Full exit of remaining position |
MO is a stealth buy at $65.19—a defensive compounder trading below the 50 SMA at $70.45 while the 200 SMA at $64.26 holds, offering a 6.63% dividend yield backed by $9.07B in annual FCF with 1.30x dividend coverage and 0.495 beta, where the 13% drawdown is a tactical discount to a structurally intact long-term uptrend.
| Indicator | Value | Signal |
|---|---|---|
| close | $65.19 | neutral |
| 10 EMA | $66.05 | bearish |
| 50 SMA | $70.45 | bearish |
| 200 SMA | $64.26 | bullish |
| RSI (14) | 38.31 | bearish |
| RSI (14) Low | 30.77 (Aug 12) | bearish |
| MACD | -1.88 | bearish |
| MACD Signal | -1.47 | bearish |
| MACD Histogram | -0.41 | bearish |
| Bollinger Middle | $68.59 | bearish |
| Bollinger Upper | $75.65 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Rallies toward $66.05-$67.00
Then: Trim into strength, not weakness
MO's cash flow fortress makes the dividend bulletproof: $9.07B in FCF covers the $6.96B dividend 1.30x, with a forward PE of just 11.12x implying 73% payout ratio—sustainable, not stretched.
↩ rebuts: “Bear's suggestion that secular cigarette decline threatens the fundamental thesis”
EV: +8.1% to $70.45 (50 SMA first target), +15%+ on momentum recovery to $75+ · concedes: NJOY impairment of $1.6B+ cumulative writedowns since 2023 is a legitimate strategic risk; Forward PE of 11.12x implying 23% EPS growth may be optimistic given MO's core business dynamics; Near-term technical picture is 'ugly' with MACD at -1.88 and RSI at 38.31 after touching 30.77 intraday on August 12
MO at $65.19 is a value trap with deteriorating momentum, fading fundamentals, saturated income narratives, and a chart structure pointing to $53-54 (18-19% downside) rather than the bull's projected bounce to $70.45; the risk/reward is negative and the stock should be sold or aggressively trimmed.
EV: -7.8% (60% probability of drift to $53-54, 40% probability of bounce to $70.45) · concedes: MO is a real business generating real cash flow ($9B FCF); FDA marketing approval for on! pouches is a legitimate structural positive; Dividend is currently covered at 1.30x FCF; The stock may bounce if 200 SMA holds on weekly close basis with positive MACD histogram contraction; Short-side max pain is the dividend forgone (~1.5-2% in option premium decay)
→ vs conservative: 200 SMA at $64.26 is not a floor, it's a countdown trigger; waiting for confirmation means selling after a 13% loss rather than trimming before
→ vs conservative: Adding on weakness toward -9% pullback zone is catching a falling knife, not value investing; media dividend narrative is saturated
→ vs conservative: 5-year +97.1% total return anchored on backward-looking multiple expansion in falling-rate regime; regime has changed with 30-year yields at 19-year highs
→ vs neutral: 'Modestly cheap at 13.72x P/E' ignores that forward P/E implies 23% EPS growth that doesn't exist; fair value is built on sand
→ vs neutral: 'Maintain core position' ignores that dividend itself is the risk with 1.30x coverage and 10% revenue decline
→ vs neutral: 'Add on weakness' advice ignores 18-19% downside vs 8.1% upside asymmetric risk/reward that is 2-to-1 against the holder
| bearish |
| Bollinger Lower | $61.53 | bearish |
| ATR | $1.79 | neutral |
Support: 64.26 · 61.53 · 53 · 54 | Resistance: 66.05 · 68.59 · 70.45 · 73 · 75
Technical posture is bearish but at a critical support confluence: price is below all short- and medium-term moving averages, oversold on RSI, with negative and widening MACD momentum, yet only $0.93 above the long-term 200 SMA at $64.26. With $1.79 of daily volatility (ATR), the $64.26–$66.00 zone represents the decisive inflection point where the next move will likely originate. The bias favors caution/defensive posture; a confirmed hold of the 200 SMA with momentum reversal (MACD histogram contraction, RSI above 50) would form a bullish setup, while a close below $64.26 would shift bias decisively bearish targeting the $61.50 lower band. Final stance: HOLD with bearish tactical bias, awaiting confirmation at the 200 SMA before committing fresh capital.
Market Cap
$108.85B
P/E (TTM)
13.72x
Forward P/E
11.12x
PEG Ratio
2.59
P/B
-40.79x
Dividend Yield
6.63%
Beta
0.495
52-Week High
$77.06
52-Week Low
$54.70
50-Day MA
$70.70
200-Day MA
$65.68
EPS (TTM)
$4.75
Forward EPS
$5.86
Total Revenue FY2022 (ex-excise)
$20,688M
Total Revenue FY2023 (ex-excise)
$20,502M
Total Revenue FY2024 (ex-excise)
$20,444M
Total Revenue FY2025 (ex-excise)
$20,139M
Operating Revenue FY2022 (incl. excise)
$25,096M
Operating Revenue FY2023 (incl. excise)
$24,483M
Operating Revenue FY2024 (incl. excise)
$24,018M
Operating Revenue FY2025 (incl. excise)
$23,279M
Gross Profit FY2022
$14,246M
Gross Profit FY2023
$14,284M
Gross Profit FY2024
$14,367M
Gross Profit FY2025
$14,542M
Gross Profit (TTM)
$17.82B
Operating Income FY2022
$11,919M
Operating Income FY2023
$11,547M
Operating Income FY2024
$11,630M
Operating Income FY2025
$12,035M
EBITDA FY2022 (reported)
$8,743M
EBITDA FY2023 (reported)
$12,349M
EBITDA FY2024 (reported)
$15,068M
EBITDA FY2025 (reported)
$10,832M
Normalized EBITDA FY2022
$8,743M
Normalized EBITDA FY2023
$12,349M
Normalized EBITDA FY2024
$12,757M
Normalized EBITDA FY2025
$12,968M
Net Income FY2022
$5,764M
Net Income FY2023
$8,130M
Net Income FY2024
$11,264M
Net Income FY2025
$6,947M
Diluted EPS FY2022
$3.19
Diluted EPS FY2023
$4.57
Diluted EPS FY2024
$6.54
Diluted EPS FY2025
$4.12
Q1'25 Revenue
$5,290M
Q1'25 Net Income
$2,378M
Q1'25 Diluted EPS
$1.41
Q1'25 OCF
$205M
Q2'25 Revenue
$5,251M
Q2'25 Net Income
$2,378M
Q2'25 Diluted EPS
$1.41
Q2'25 OCF
$3,094M
Q3'25 Revenue
$5,081M
Q3'25 Net Income
$2,375M
Q3'25 Diluted EPS
$1.41
Q3'25 OCF
$3,271M
Q4'25 Revenue
$5,079M
Q4'25 Net Income
$1,117M
Q4'25 OCF
$2,324M
Q1'26 Revenue
$4,758M
Q1'26 Net Income
$2,183M
Q1'26 Diluted EPS
$1.30
Q1'26 OCF
$2,324M
Q2'26 Revenue
$5,356M
Q2'26 Net Income
$2,298M
Q2'26 Diluted EPS
$1.37
Q2'26 OCF
$719M
Total Assets Q2'26
$33,374M
Total Assets FY2025
$35,017M
Total Assets FY2024
$35,177M
Total Assets FY2023
$38,570M
Cash & Equivalents Q2'26
$2,367M
Cash & Equivalents FY2025
$4,474M
Cash & Equivalents FY2024
$3,127M
Cash & Equivalents FY2023
$3,686M
Total Debt Q2'26
$24,577M
Total Debt FY2025
$25,709M
Total Debt FY2024
$24,926M
Total Debt FY2023
$26,233M
Long-Term Debt Q2'26
$22,893M
Long-Term Debt FY2025
$24,140M
Long-Term Debt FY2024
$23,399M
Long-Term Debt FY2023
$25,112M
Net Debt Q2'26
$22,210M
Net Debt FY2025
$21,235M
Net Debt FY2024
$21,799M
Net Debt FY2023
$22,547M
Treasury Stock Q2'26
$43,505M
Treasury Stock FY2025
$43,183M
Treasury Stock FY2024
$42,194M
Treasury Stock FY2023
$38,802M
Stockholders' Equity Q2'26
-$2,668M
Stockholders' Equity FY2025
-$3,502M
Stockholders' Equity FY2024
-$2,238M
Stockholders' Equity FY2023
-$3,540M
Tangible Book Value Q2'26
-$20,305M
Tangible Book Value FY2025
-$21,165M
Tangible Book Value FY2024
-$22,156M
Tangible Book Value FY2023
-$24,017M
Goodwill + Intangibles Q2'26
$17,637M
Goodwill + Intangibles FY2025
$17,663M
Goodwill + Intangibles FY2024
$19,918M
Goodwill + Intangibles FY2023
$20,477M
Current Ratio Q2'26
0.52
Current Ratio FY2025
0.52
Current Ratio FY2024
0.51
Current Ratio FY2023
0.49
Operating Cash Flow FY2022
$8,256M
Operating Cash Flow FY2023
$9,287M
Operating Cash Flow FY2024
$8,753M
Operating Cash Flow FY2025
$9,290M
CapEx FY2022
$205M
CapEx FY2023
$196M
CapEx FY2024
$142M
CapEx FY2025
$216M
Free Cash Flow FY2022
$8,051M
Free Cash Flow FY2023
$9,091M
Free Cash Flow FY2024
$8,611M
Free Cash Flow FY2025
$9,074M
Cash Dividends Paid FY2022
$6,599M
Cash Dividends Paid FY2023
$6,779M
Cash Dividends Paid FY2024
$6,845M
Cash Dividends Paid FY2025
$6,960M
Share Repurchases FY2022
$1,825M
Share Repurchases FY2023
$1,000M
Share Repurchases FY2024
$3,400M
Share Repurchases FY2025
$1,000M
Operating Margin
61.46%
Net Margin
38.99%
ROA
29.55%
Debt/EBITDA
~1.4x
FCF/Net Income
~130%
% FCF Returned
88%
Interest Expense 2025
$1.18B
Interest Expense 2023
$1.07B
Pension Obligations
$1.06B
NJOY Cumulative Writedowns
$1.6B+
2024 AB InBev Divestiture Gain
$2.7B
2025 Unusual Charges
$1.26B
2022 AB InBev Equity Loss
$3.47B
Normalized Earnings Power (EBITDA)
~$13B
Normalized EPS
~$5.20+
Tax Rate Q2'26
~21.5%
Dividend Coverage (FCF)
1.30x
Cigarette Volume Decline
~4-6%/yr
Goodwill FY2026 Q2
$5.79B
Intangibles FY2026 Q2
$11.85B
Strengths
Concerns
Altria Group (MO) is a classic late-cycle defensive income investment generating ~$9B+ annual free cash flow from its dominant U.S. tobacco franchise with best-in-class margins (61% operating, 39% net), supporting a 6.63% dividend yield with 88% FCF returned to shareholders. However, the company faces structural cigarette volume decline (~4-6%/year), has absorbed $1.6B+ in NJOY impairment charges for its smoke-free pivot, and carries $24.6B in debt against negative stockholders' equity from aggressive buybacks. The stock trades near 52-week highs ($77 vs $54.70 low) with a forward P/E of 11.12x implying ~23% EPS growth that analysts view as overly optimistic given normalized earnings power of ~$5.20/share—best suited for yield-focused investors prioritizing income over growth.
Macro: Rates stay higher-for-longer with no recession: Polymarket shows 85% probability of no Fed cuts in 2026 (-0.5pp WoW) and only 8% US recession odds by end of 2026 (-1.0pp WoW). The 30-year Treasury reached a 19-year high this week as US debt approaches $40T, triggering a bond-led equity selloff with tech leadership cracking. Crude oil extending gains adds headline inflation pressure supportive of consumer-staples pricing power but negative for discretionary names. FRED macro series (CPI, unemployment, fed funds, 10Y) were unavailable due to a missing API key; macro commentary is anchored to Reuters/Yahoo headlines and Polymarket implied probabilities.